Overview

Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma

Status:
Completed
Trial end date:
2018-05-02
Target enrollment:
Participant gender:
Summary
Evaluation of the optimal dose for the efficacy in reduction of intraocular pressure and safety of PHP-201 ophthalmic solution in patients with normal tension glaucoma
Phase:
Phase 2
Details
Lead Sponsor:
pH Pharma
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions